Press Release Archive
Press Releases
September 2022
09.20.2022
09.20.2022
09.19.2022
Research and Pipeline Research Vaccines Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union
09.15.2022
09.14.2022
09.14.2022
Research and Pipeline Research Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
09.12.2022
09.09.2022
Prescription Medicines Medicines FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata
09.07.2022
09.06.2022
09.06.2022
09.01.2022
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.